Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase.

Selective small molecule inhibitors of Tie-2 kinase are important tools for the validation of Tie-2 signaling in pathological angiogenesis. Reported herein is the optimization of a nonselective scaffold into a potent and highly selective inhibitor of Tie-2 kinase.

[1]  J. Adams,et al.  Optimization of triarylimidazoles for Tie2: influence of conformation on potency. , 2007, Bioorganic & medicinal chemistry letters.

[2]  J. Folkman.  Opinion: Angiogenesis: an organizing principle for drug discovery? , 2007, Nature Reviews Drug Discovery.

[3]  David Powers,et al.  Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase. , 2007, Journal of medicinal chemistry.

[4]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[5]  M. Dewhirst,et al.  Functional significance of Tie2 signaling in the adult vasculature. , 2004, Recent progress in hormone research.

[6]  D. Williams,et al.  Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights. , 2004, Current medicinal chemistry.

[7]  Hui Yang,et al.  Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase , 2005, FEBS letters.

[8]  Richard Kendall,et al.  Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor. , 2007, Journal of medicinal chemistry.

[9]  Marc Schmidt,et al.  Ablation of the spindle assembly checkpoint by a compound targeting Mps1 , 2005, EMBO reports.

[10]  K. Yi,et al.  Di-2-Pyridyl thionocarbonate. A new reagent for the preparation of isothiocyanates and carbodiimides. , 1985 .

[11]  Nicholas Downing,et al.  A one-pot method for the synthesis of 2-aminobenzimidazoles and related heterocycles , 2006 .

[12]  A M Hassell,et al.  Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. , 2000, Structure.

[13]  G. Mcmahon,et al.  Receptor tyrosine kinases as targets for inhibition of angiogenesis , 1997 .

[14]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[15]  W. Earnshaw,et al.  The cellular geography of Aurora kinases , 2003, Nature Reviews Molecular Cell Biology.

[16]  Jin‐Ho Choi,et al.  Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. , 2006, Cardiovascular research.

[17]  K. Alitalo,et al.  Tie receptors: new modulators of angiogenic and lymphangiogenic responses , 2001, Nature Reviews Molecular Cell Biology.